뉴스벤징가
FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics
· 발표
기사 요약
Lantheus receives FDA approval for PET imaging agent used to evaluate adults for Alzheimer's disease by identifying tau pathology.
기사 원문에서 발췌했어요.Lantheus receives FDA approval for PET imaging agent used to evaluate adults for Alzheimer's disease by identifying tau pathology.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…